Literature DB >> 29601898

Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2.

Judith van Vliet1, Alide A Tieleman2, Aad Verrips3, Hans Timmerman4, Robert T M van Dongen5, Baziel G M van Engelen2, Oliver H G Wilder-Smith6.   

Abstract

Pain is a common but often ignored symptom in patients with myotonic dystrophy type 2 (DM2). In this explorative study, we assessed qualitative and quantitative aspects of pain in DM2 using 4 questionnaires and quantitative sensory testing. A disease control group (fibromyalgia [FMS]) as well as healthy controls were used to compare the results, because pain in DM2 shows many clinical similarities to pain in FMS. Thirty-four patients with genetically confirmed DM2 (71% female, mean age 54 years), 28 patients with FMS, and 33 healthy controls were included, age- as well as sex-matched. Pain prevalence was 65% in DM2, 100% in FMS (P < .001), and 15% in healthy controls (P < .001). The mean of the pressure pain thresholds was lower in DM2 than in healthy controls (P = .016), with the largest differences in the rectus femoris, trapezius, and thenar muscles. Mechanical and electric pain thresholds were significantly higher in DM2 than in FMS, and no differences were found in electric pain thresholds between DM2 and healthy controls. These results confirm that pain is a frequent and important symptom in patients with DM2, affecting quality of life. Peripheral mechanisms of pain seem to play a role in DM2. The widespreadness of the hyperalgesia suggests central sensitization, but this finding was not supported by the other results. This study opens new avenues for further research and eventually novel treatment strategies, in DM2 as well as in other muscular disorders. PERSPECTIVE: This article presents qualitative as well as quantitative aspects of pain in patients with DM2. Pain is a frequent and important symptom in patients with DM2, affecting quality of life. We found mechanical hyperalgesia, indicative of a peripheral mechanism of pain. The widespreadness of hyperalgesia may suggest central sensitization, but this finding was not supported by other results and needs further exploration.
Copyright © 2018 The American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Myotonic dystrophy type 2; central sensitization; fibromyalgia syndrome; pain; quantitative sensory testing

Mesh:

Year:  2018        PMID: 29601898     DOI: 10.1016/j.jpain.2018.03.006

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  4 in total

Review 1.  Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.

Authors:  Andrea Romigi; Michelangelo Maestri; Carmine Nicoletta; Giuseppe Vitrani; Marco Caccamo; Gabriele Siciliano; Enrica Bonanni; Diego Centonze; Alessandro Sanduzzi
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

2.  Brain Activation in a Cynomolgus Macaque Model of Chymopapain-Induced Discogenic Low Back Pain: A Preliminary Study.

Authors:  Hiroki Ushirozako; Go Yoshida; Daisuke Togawa; Takao Omura; Tomohiko Hasegawa; Yu Yamato; Tomohiro Banno; Hideyuki Arima; Shin Oe; Yuki Mihara; Tomohiro Yamada; Takahiro Natsume; Shinya Ogawa; Yuji Awaga; Hiroyuki Takamatsu; Yukihiro Matsuyama
Journal:  Spine Surg Relat Res       Date:  2019-04-05

3.  Myotonic dystrophy type 2: the 2020 update.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2020-12-01

4.  Myalgia in 30 Patients with Suspected Myopathy.

Authors:  Diana Lehmann Urban; Elizabeth Lehmann; Leila Motlagh Scholle; Torsten Kraya
Journal:  Int J Environ Res Public Health       Date:  2020-04-06       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.